VT-105
Ar gyfer ymchwil wyddonol yn unig, nid ar gyfer cleifion.
Manylion Cynnyrch
Tagiau Cynnyrch
| Maint Pecyn | Argaeledd | Pris (USD) |
| 0.1G | Mewn Stoc | 360 |
| 0.5G | Mewn Stoc | 790 |
| 1G | Mewn Stoc | 1050 |
Enw Cemegol:
(S)-N-(1-(pyridin-2-yl)ethyl)-8-(4-(trifflworomethyl)ffenyl)quinoline-3-carboxamid
Cod gwenu:
FC(F)(F)C(C=C1)=CC=C1C2=CC=CC3=CC(C(N[C@H)(C)C4=NC=CC=C4)=O)=CN= C23
Cod InChi:
InChI=1S/C24H18F3N3O/c1-15(21-7-2-3-12-28-21)30-23(31)18-13-17-5-4-6-20(22 (17)29-14-18)16-8-10-19(11-9-16)24(25,26)27/h2-15H,1H3,(H,30,31)/t15-/m0/ s1
Allwedd InChi:
FUKXXBXVSANFJK-HNNXBMFYSA-N
Allweddair:
2417718-38-6 ; CAS: 2417718-38-6 ; CAS: 2417718-38-6 ;VT-105; VT 105; VT105
Hydoddedd:
Storio:Sych, tywyll ac ar 0 - 4 C am dymor byr (dyddiau i wythnosau) neu -20 C am dymor hir (misoedd i flynyddoedd).
Disgrifiad:
Mae VT-105 yn atalydd hunan palmitoylation TEAD grymus a detholus.
Targed: TEAD


![4H-1,3-Dioxolo[4,5-c]pyrrole-4-carboxamid, N-(3-cloro-4-fflworophenyl)tetrahydro-N,2,2-trimethyl-6-oxo-, (3aS,4S ,6aS)-](http://www.caerulumpharm.com/uploads/20240605095550.jpg)




